Details for Patent: 7,977,324

Which drugs does patent 7,977,324 protect, and when does it expire?

Patent 7,977,324 protects OVIDE and is included in one NDA.

This patent has nine patent family members in six countries.

Summary for Patent: 7,977,324

Title:	Process for preparing malathion for pharmaceutical use
Abstract:	The present invention provides a process for preparing a highly pure form of malathion having a reduced level of toxic impurities. In addition, the malathion prepared by the process of this invention is storage stable. The level of toxic impurities in the malathion, e.g., isomalathion, O,O,S-trimethyl phosphorodithioate (MeOOSPS), O,O,S-trimethyl phosphorothioate (MeOOSPO), O,S,S-trimethyl phosphorodithioate (MeOSSPO), malaoxon, isomalathion, diethyl fumarate, methyl malathion, dimethyl malathion, O,O-methyl,ethyl-S-(1,2-dicarboethoxy)ethyl-phosphorodithioate are lower than that of any other commercial preparation of malathion that may be used for pharmaceutical purposes.
Inventor(s):	Daniella Gutman, Wael Baidussi
Assignee:	Taro Pharmaceutical Industries Ltd
Application Number:	US12/353,691
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,977,324
Patent Claim Types: see list of patent claims	Formulation; Compound;

Drugs Protected by US Patent 7,977,324

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Taro	OVIDE	malathion	LOTION;TOPICAL	018613-001	Aug 2, 1982		DISCN	Yes	No	7,977,324		Y

International Family Members for US Patent 7,977,324

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Brazil	PI0612686
Canada	2612578
China	101287374
China	103087095
European Patent Office	1898707
Japan	2009500422